Product image of Atectura Breezhaler (Mometasone Furoate, Indacaterol) supplied by GNH India

Atectura Breezhaler

Active Ingredient:
Mometasone Furoate, Indacaterol
Origin:
EU

Atectura Breezhaler (Mometasone Furoate, Indacaterol)

Atectura Breezhaler combines Mometasone Furoate and Indacaterol for inhalation use. It is designed to manage respiratory conditions by reducing inflammation and improving airflow. This medication is suitable for long-term maintenance therapy.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Atectura Breezhaler is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The combination of Mometasone Furoate, a corticosteroid, and Indacaterol, a long-acting beta-agonist, works to reduce inflammation in the lungs and improve breathing. This medication is often prescribed for individuals who require both anti-inflammatory and bronchodilator effects to manage their respiratory symptoms effectively.

Side Effects

  • Common effects of Atectura Breezhaler may include improved breathing and reduced symptoms such as wheezing and shortness of breath. Some users might experience mild side effects like throat irritation or hoarseness. It is important to use this medication as directed by a healthcare professional to minimize potential side effects.

Precautions & Warnings

  • Atectura Breezhaler should be used with caution in individuals with a history of severe hypersensitivity to any of its components. It is important to follow the prescribed dosage and administration instructions to avoid potential side effects. Regular monitoring by a healthcare professional is recommended to ensure the medication's effectiveness and safety.

Avoid Interactions

  • Atectura Breezhaler may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

Frequently Asked Questions

Atectura Breezhaler is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma.

Atectura Breezhaler combines Mometasone Furoate and Indacaterol to reduce lung inflammation and improve airflow.

Common side effects may include throat irritation, hoarseness, and improved breathing.

Atectura Breezhaler may interact with other medications, so it is important to consult a healthcare professional before combining it with other treatments.

Atectura Breezhaler should be stored at room temperature, away from moisture and heat.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate, Indacaterol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT